Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Oct 22;7(10):4253-82.
doi: 10.3390/toxins7104253.

Comparative Ochratoxin Toxicity: A Review of the Available Data

Affiliations
Free PMC article
Review

Comparative Ochratoxin Toxicity: A Review of the Available Data

Alexandra H Heussner et al. Toxins (Basel). .
Free PMC article

Abstract

Ochratoxins are a group of mycotoxins produced by a variety of moulds. Ochratoxin A (OTA), the most prominent member of this toxin family, was first described by van der Merwe et al. in Nature in 1965. Dietary exposure to OTA represents a serious health issue and has been associated with several human and animal diseases including poultry ochratoxicosis, porcine nephropathy, human endemic nephropathies and urinary tract tumours in humans. More than 30 years ago, OTA was shown to be carcinogenic in rodents and since then extensive research has been performed in order to investigate its mode of action, however, this is still under debate. OTA is regarded as the most toxic family member, however, other ochratoxins or their metabolites and, in particular, ochratoxin mixtures or combinations with other mycotoxins may represent serious threats to human and animal health. This review summarises and evaluates current knowledge about the differential and comparative toxicity of the ochratoxin group.

Keywords: biosynthesis; comparative toxicity; detection; metabolites; ochratoxin.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Overview of ochratoxin A (OTA) metabolites in animals and humans. Ochratoxins are differentially metabolised in various animals and humans depending on the metabolising enzymes present in liver, kidneys and/or gut. OTA, ochratoxin A; OTB, ochratoxin B; OTC, ochratoxin C; OTα, ochratoxin α; OTβ, ochratoxin β, OTHQ, OT hydroquinone; 4R-OH-OTB, 4R-hydroxyochratoxin B; OP-OTA, lactone-opened OTA; 10-OH-OTA, 10-hydroxyochratoxin A; 4R-OH-OTA, 4R-hydroxyochratoxin A; 4S-OH-OTA, 4S-hydroxyochratoxin A; 4S-OH-OTB, 4S-hydroxyochratoxin B. The respective metabolite is the main metabolite in the underlined taxa (for rodents, data of different authors is contradictory). Genera in brackets represent those where the metabolite has been detected, although it may be present in other animals or humans as well. Summarised from [52,53,92].
Figure 2
Figure 2
Comparison of cellular uptake of [3H]OTA and [3H]OTB. PKC, primary porcine kidney cells (male); HKC, primary human kidney cells (male). Columns represent means from at least three independent replicates ± SEM; modified from O’Brien et al. with permission [169].

Similar articles

Cited by

References

    1. Van der Merwe K., Steyn P., Fourie L., Scott D., Theron J. Ochratoxin A, a toxic metabolite produced by Aspergillus ochraceus Wilh. Nature. 1965;205:1112–1113. doi: 10.1038/2051112a0. - DOI - PubMed
    1. O’Brien E., Dietrich D. Mycotoxins affecting the kidney. In: Hook J., editor. Toxicology of Kidney. CRC Press; Boca Raton, FL, USA: 2004. pp. 895–936.
    1. Streit E., Schatzmayr G., Tassis P., Tzika E., Marin D., Taranu I., Tabuc C., Nicolau A., Aprodu I., Puel O., et al. Current situation of mycotoxin contamination and co-occurrence in animal feed-focus on Europe. Toxins. 2012;4:788–809. doi: 10.3390/toxins4100788. - DOI - PMC - PubMed
    1. Bellver Soto J., Fernández-Franzón M., Ruiz M., Juan-García A. Presence of ochratoxin A (OTA) mycotoxin in alcoholic drinks from southern European countries: Wine and beer. J. Agric. Food Chem. 2014;62:7643–7651. doi: 10.1021/jf501737h. - DOI - PubMed
    1. EC . Assessment of Dietary Intake of Ochratoxin A by the Population of EU Member States. Directorate-General Health and Consumer Protection, European Commission; Rome, Italy: 2002. Report of the Scientific Cooperation, Task 3.2.7.

LinkOut - more resources